Amassing the Clinical Evidence for Optimized Dyslipidemia Ma - Episode 12
The MD Magazine Peer Exchange “Amassing the Clinical Evidence for Optimized Dyslipidemia Management: Vitamin D, Long-Term Statin Outcomes, and PCSK9 Inhibition” features expert insight and analysis of the latest information on managing hypertension and hyperlipidemia, and in-depth discussion on the use of PCSK9 inhibitors in practice.
This Peer Exchange is moderated by Peter Salgo, MD, professor of medicine and anesthesiology at Columbia University and an associate director of surgical intensive care at the New York-Presbyterian Hospital in New York City.
The panelists are:
Now that statins are generic medications and can be acquired for very little money, it is extremely cost-effective to treat patients who need statins. Failing to treat high-risk patients with statins can actually result in high cost to society because of the strokes and heart attacks that will occur and that society will need to treat, said Watson.